KIBRA和PTPN14在Hippo信号通路及其他方面的调节作用
The Regulatory Role of KIBRA and PTPN14 in Hippo Signaling and Beyond.
作者信息
Wilson Kayla E, Yang Nuo, Mussell Ashley L, Zhang Jianmin
机构信息
Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
出版信息
Genes (Basel). 2016 May 27;7(6):23. doi: 10.3390/genes7060023.
Abstract
The Hippo signaling pathway regulates cellular proliferation and survival, thus exerting profound effects on normal cell fate and tumorigenesis. Pivotal effectors of this pathway are YAP/TAZ, transcriptional co-activators whose dysfunction contributes to the development of cancer. Complex networks of intracellular and extracellular signaling pathways that modulate YAP and TAZ activities have recently been identified. Among them, KIBRA and PTPN14 are two evolutionarily-conserved and important YAP/TAZ upstream regulators. They can negatively regulate YAP/TAZ functions separately or in concert. In this review, we summarize the current and emerging regulatory roles of KIBRA and PTPN14 in the Hippo pathway and their functions in cancer.
摘要
河马信号通路调节细胞增殖和存活，从而对正常细胞命运和肿瘤发生产生深远影响。该通路的关键效应因子是YAP/TAZ，即转录共激活因子，其功能失调会促进癌症的发展。最近已经确定了调节YAP和TAZ活性的细胞内和细胞外信号通路的复杂网络。其中，KIBRA和PTPN14是两个进化保守且重要的YAP/TAZ上游调节因子。它们可以单独或协同负向调节YAP/TAZ的功能。在本综述中，我们总结了KIBRA和PTPN14在河马通路中的当前和新出现的调节作用及其在癌症中的功能。
相似文献
1
The Regulatory Role of KIBRA and PTPN14 in Hippo Signaling and Beyond.KIBRA和PTPN14在Hippo信号通路及其他方面的调节作用
Genes (Basel). 2016 May 27;7(6):23. doi: 10.3390/genes7060023.
2
PTPN14 forms a complex with Kibra and LATS1 proteins and negatively regulates the YAP oncogenic function.蛋白酪氨酸磷酸酶非受体型14（PTPN14）与Kibra和大肿瘤抑制激酶1（LATS1）蛋白形成复合物，并负向调节Yes相关蛋白（YAP）的致癌功能。
J Biol Chem. 2014 Aug 22;289(34):23693-700. doi: 10.1074/jbc.M113.534701. Epub 2014 Jul 14.
3
Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.靶向 Hippo 信号通路进行组织再生和癌症治疗。
Genes (Basel). 2016 Aug 30;7(9):55. doi: 10.3390/genes7090055.
4
The Hippo signaling pathway provides novel anti-cancer drug targets.河马信号通路提供了新的抗癌药物靶点。
Oncotarget. 2017 Feb 28;8(9):16084-16098. doi: 10.18632/oncotarget.14306.
5
PTPN14 interacts with and negatively regulates the oncogenic function of YAP.PTPN14 与 YAP 相互作用，并负向调节其致癌功能。
Oncogene. 2013 Mar 7;32(10):1266-73. doi: 10.1038/onc.2012.147. Epub 2012 Apr 23.
6
The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease.Hippo 通路效应物 TAZ 和 YAP 在发育、稳态和疾病中的作用。
Development. 2014 Apr;141(8):1614-26. doi: 10.1242/dev.102376.
7
The biology of YAP/TAZ: hippo signaling and beyond.YAP/TAZ 的生物学： Hippo 信号通路及其他。
Physiol Rev. 2014 Oct;94(4):1287-312. doi: 10.1152/physrev.00005.2014.
8
Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis.河马通路-YAP/TAZ信号在血管生成中的作用。
Front Cell Dev Biol. 2019 Apr 10;7:49. doi: 10.3389/fcell.2019.00049. eCollection 2019.
9
The Hippo-YAP pathway: new connections between regulation of organ size and cancer.河马 - YAP信号通路：器官大小调控与癌症之间的新联系
Curr Opin Cell Biol. 2008 Dec;20(6):638-46. doi: 10.1016/j.ceb.2008.10.001. Epub 2008 Nov 18.
10
YAP and the Hippo pathway in pediatric cancer.YAP与小儿癌症中的河马通路
Mol Cell Oncol. 2017 Feb 25;4(3):e1295127. doi: 10.1080/23723556.2017.1295127. eCollection 2017.
引用本文的文献
1
Common skin cancers and their association with other non-cutaneous primary malignancies: a review of the literature.常见皮肤癌及其与其他非皮肤原发性恶性肿瘤的关系：文献复习。
Med Oncol. 2024 May 17;41(6):157. doi: 10.1007/s12032-024-02385-7.
2
Identification of PTPN12 Phosphatase as a Novel Negative Regulator of Hippo Pathway Effectors YAP/TAZ in Breast Cancer.鉴定 PTPN12 磷酸酶为乳腺癌 Hippo 通路效应物 YAP/TAZ 的新型负调控因子。
Int J Mol Sci. 2024 Apr 5;25(7):4064. doi: 10.3390/ijms25074064.
3
HPV18 E7 inhibits LATS1 kinase and activates YAP1 by degrading PTPN14.人乳头瘤病毒18型E7蛋白通过降解蛋白酪氨酸磷酸酶N14抑制大肿瘤抑制激酶1并激活Yes相关蛋白1。
bioRxiv. 2024 Jun 19:2024.03.07.583953. doi: 10.1101/2024.03.07.583953.
4
WWC1/2 regulate spinogenesis and cognition in mice by stabilizing AMOT.WWC1/2 通过稳定 AMOT 来调节小鼠的 spinogenesis 和认知。
Cell Death Dis. 2023 Aug 1;14(8):491. doi: 10.1038/s41419-023-06020-7.
5
Mechanical Properties of Glioblastoma: Perspectives for YAP/TAZ Signaling Pathway and Beyond.胶质母细胞瘤的力学特性：YAP/TAZ信号通路及其他方面的研究前景
Diseases. 2023 Jun 14;11(2):86. doi: 10.3390/diseases11020086.
6
KIBRA upregulation increases susceptibility to podocyte injury and glomerular disease progression.KIBRA 上调增加了足细胞损伤和肾小球疾病进展的易感性。
JCI Insight. 2023 Apr 10;8(7):e165002. doi: 10.1172/jci.insight.165002.
7
Evaluation of Quantification and Normalization Strategies for Phosphoprotein Phosphatase Affinity Proteomics: Application to Breast Cancer Signaling.磷酸化酶亲和蛋白质组学定量和归一化策略的评估：在乳腺癌信号转导中的应用。
J Proteome Res. 2023 Jan 6;22(1):47-61. doi: 10.1021/acs.jproteome.2c00465. Epub 2022 Nov 30.
8
Cell-Cell Contact Mediates Gene Expression and Fate Choice of Human Neural Stem/Progenitor Cells.细胞间接触介导人类神经干细胞/祖细胞的基因表达和命运选择。
Cells. 2022 May 25;11(11):1741. doi: 10.3390/cells11111741.
9
, A Key Predictor of Prognosis for Pancreatic Adenocarcinoma, Significantly Regulates Cell Cycles, Apoptosis, and Metastasis., 一种胰腺腺癌预后的关键预测因子，显著调控细胞周期、凋亡和转移。
Front Immunol. 2022 Jan 27;13:805311. doi: 10.3389/fimmu.2022.805311. eCollection 2022.
10
FAT1 and PTPN14 Regulate the Malignant Progression and Chemotherapy Resistance of Esophageal Cancer through the Hippo Signaling Pathway.FAT1 和 PTPN14 通过 Hippo 信号通路调节食管癌的恶性进展和化疗耐药性。
Anal Cell Pathol (Amst). 2021 Oct 19;2021:9290372. doi: 10.1155/2021/9290372. eCollection 2021.
本文引用的文献
1
Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma.基因组分析鉴定出皮肤基底细胞癌的新驱动基因和进展途径。
Nat Genet. 2016 Apr;48(4):398-406. doi: 10.1038/ng.3525. Epub 2016 Mar 7.
2
Phosphorylation-Dependent Regulation of the DNA Damage Response of Adaptor Protein KIBRA in Cancer Cells.衔接蛋白KIBRA在癌细胞中DNA损伤反应的磷酸化依赖性调控
Mol Cell Biol. 2016 Apr 15;36(9):1354-65. doi: 10.1128/MCB.01004-15. Print 2016 May.
3
Human phosphatase CDC14A is recruited to the cell leading edge to regulate cell migration and adhesion.人类磷酸酶CDC14A被招募到细胞前沿以调节细胞迁移和黏附。
Proc Natl Acad Sci U S A. 2016 Jan 26;113(4):990-5. doi: 10.1073/pnas.1515605113. Epub 2016 Jan 8.
4
Kibra and aPKC regulate starvation-induced autophagy in Drosophila.Kibra和非典型蛋白激酶C调节果蝇中饥饿诱导的自噬。
Biochem Biophys Res Commun. 2015;468(1-2):1-7. doi: 10.1016/j.bbrc.2015.11.011. Epub 2015 Nov 10.
5
Mutational dynamics between primary and relapse neuroblastomas.原发和复发神经母细胞瘤之间的突变动态。
Nat Genet. 2015 Aug;47(8):872-7. doi: 10.1038/ng.3349. Epub 2015 Jun 29.
6
Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells.Sox2拮抗Hippo信号通路以维持癌细胞的干性。
Nat Commun. 2015 Apr 2;6:6411. doi: 10.1038/ncomms7411.
7
MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.微小RNA-21通过靶向蛋白酪氨酸磷酸酶非受体型14和磷酸酶及张力蛋白同源物在体外和体内促进肝内胆管癌的增殖和生长。
Oncotarget. 2015 Mar 20;6(8):5932-46. doi: 10.18632/oncotarget.3465.
8
The tyrosine phosphatase PTPN14 (Pez) inhibits metastasis by altering protein trafficking.酪氨酸磷酸酶PTPN14（Pez）通过改变蛋白质运输来抑制转移。
Sci Signal. 2015 Feb 17;8(364):ra18. doi: 10.1126/scisignal.2005547.
9
A novel phosphatidic acid-protein-tyrosine phosphatase D2 axis is essential for ERBB2 signaling in mammary epithelial cells.一种新型的磷脂酸-蛋白酪氨酸磷酸酶D2轴对于乳腺上皮细胞中的ERBB2信号传导至关重要。
J Biol Chem. 2015 Apr 10;290(15):9646-59. doi: 10.1074/jbc.M114.627968. Epub 2015 Feb 13.
10
PTPN14 forms a complex with Kibra and LATS1 proteins and negatively regulates the YAP oncogenic function.蛋白酪氨酸磷酸酶非受体型14（PTPN14）与Kibra和大肿瘤抑制激酶1（LATS1）蛋白形成复合物，并负向调节Yes相关蛋白（YAP）的致癌功能。
J Biol Chem. 2014 Aug 22;289(34):23693-700. doi: 10.1074/jbc.M113.534701. Epub 2014 Jul 14.
Zotero 插件